CALCIKEL 300 X 500ML // Calcium gluconate monohydrate + Magnesium chloride hexahydrate
CALCIKEL 300 X 500ML // Calcium gluconate monohydrate + Magnesium chloride hexahydrate
NAME OF THE VETERINARY MEDICINAL PRODUCT
CALCIKEL 300 X 500 ML
Injectable solution for cows and sheep.
STATEMENT OF ACTIVE SUBSTANCES
1 ml contains:
Active ingredients:
Calcium gluconate monohydrate 279.24 mg;
Magnesium chloride hexahydrate 40.00 mg.
Excipients:
Methyl parahydroxybenzoate 1.00 mg.
INDICATIONS
Acute hypocalcemia in cows and sheep (puerperal paresis, milk fever);
Acute hypomagnesemia in cows (hay fever).
CONTRAINDICATIONS
Absolute contraindications: cardiac disorders.
Relative contraindications: hyperparathyroidism, renal failure, acidosis, cardiac glycoside intoxication.
Do not use in case of known hypersensitivity to one of the ingredients.
ADVERSE REACTIONS
During the following treatment due to temporary hypercalcemia, adverse effects are observed mainly on the cardiovascular system. Initially, bradycardia is observed, evolving to a slight tachycardia with an increased pulse rate, in most animals during standard therapy. In a few cases, these symptoms may progress to pronounced tachycardia, irregular pulse (extrasystoles), ending in death by heart failure (ventricular fibrillation, heart block). The incidence of adverse effects increases in the case of rapid intravenous administration.
Other toxic symptoms observed during and after the infusion are: muscle tremors, abundant salivation, lacrimation, grinding of the teeth, frequent urination and defecation, central nervous disorders ranging from depression (anorexia, weakness, prostration) to agitation and terminal excitability.
If you notice any other serious effects or any other effects not mentioned in this leaflet, please inform your veterinary surgeon.
TARGET SPECIES
Cows, sheep.
DOSAGE, ROUTE(S) OF ADMINISTRATION AND METHOD OF ADMINISTRATION
FOR SLOW INTRAVENOUS ADMINISTRATION ONLY
Adult cows (500-600 kg): 500 ml (equivalent to 12.5 g calcium + 2.4 g magnesium) or the whole bottle.
Sheep: 1 ml per kg body weight
RECOMMENDATIONS ON CORRECT ADMINISTRATION
The solution should be administered slowly intravenously, for example an infusion time of at least 5 minutes should be observed.
If possible, the solution should be warmed to near body temperature.
Necessary precautions to be taken for aseptic infusion, as far as possible.
It is recommended to carefully monitor the infusion device for air leaks.
It is recommended to monitor heart function during intravenous administration.
In case of relapse after treatment, an interval of 6 hours should be observed between the first and second treatment.
WAITING TIME
Zero days.
SPECIAL WARNINGS
An increase in the concentration of calcium in the blood may increase the therapeutic effect but also the toxic effects of cardiac glycosides, sympathomimetics and methylxanthines (e.g. caffeine).
Acute neuromuscular antagonist calcium blocks the action of aminoglycoside antibiotics. On the other hand, magnesium may increase the neuromuscular blocking effect of some drugs (e.g. muscle relaxants such as succinylcholine). Calcium forms complexes with tetracycline antibiotics leading to inactivation of their antimicrobial activity.
Rapid intravenous administration and/or overdose may cause increased symptoms of hypercalcemia.
In case of a sudden increase in heart rate or an irregular heartbeat, intravenous treatment should be discontinued immediately. Thereafter, intravenous treatment can be continued slowly, with regular monitoring of the heart.
Additional treatment is possible: Na –EDTA iv slowly.
Calcium and magnesium are incompatible with several drugs, resulting in the formation of precipitates.
However, Calcikel 300 should not be mixed with any other drug for simultaneous intravenous administration.
PRESENTATION FORM
500 ml bottle.
Caractéristiques du produit
Caractéristiques du produit
Matériaux et entretien
Matériaux et entretien
Conseils de marchandisage
Conseils de marchandisage
Partager
